Gynecological devices market seen growing to $21.72B by 2030

The gynecological devices market is projected to rise from $15.32 billion in 2026 to $21.72 billion by 2030, driven by higher rates of gynecological disorders, more women’s health infrastructure and faster adoption of minimally invasive care. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Demand for gynecological devices is tied to the rising burden of reproductive health conditions and broader access to women’s healthcare. - The market’s projected growth points to more spending on diagnosis, treatment and outpatient care across hospitals and clinics. - The report’s forecast signals continued momentum for minimally invasive procedures and digital gynecology tools.

What happened: - The Business Research Company released its Gynecological Devices Market Report 2026, covering market size, trends and a global forecast through 2035. - The market was valued at $14.07 billion in 2025 and is expected to reach $15.32 billion in 2026, a CAGR of 8.9%. - The market is projected to reach $21.72 billion by 2030, with a CAGR of 9.1%. - The report is available with a free sample download and the full market report.

The details: - Gynecological devices are specialized tools used to manage the female reproductive system, support childbirth and assist pregnancy. - The devices are used in procedures including colposcopy, loop electrical excision procedure, endometrial biopsy, IUD insertion, dilation and curettage, tubal ligation and ovarian cyst removal. - Growth drivers cited in the report include the rising prevalence of gynecological disorders, expansion of hospital and clinic facilities, wider use of diagnostic imaging, better access to essential instruments and improved healthcare access for women. - Future growth factors include stronger demand for minimally invasive treatment, more investment in women’s healthcare technology, expansion of diagnostic centers, broader use of digital health records in gynecology and more focus on early disease detection. - The report highlights several trends: more minimally invasive procedures, greater use of advanced diagnostic imaging, integration of digital gynecology software, growth in outpatient gynecological care and more patient-centric device design. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest share in 2025, while Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated key technology and future-trend analysis.

Between the lines: - The report frames women’s health as a commercial growth category, not just a clinical one. - The forecast suggests that earlier diagnosis and less invasive treatment are becoming central to purchasing decisions and product development. - The regional split points to mature demand in North America and faster infrastructure-led expansion in Asia-Pacific. - WHO reported in March 2023 that about 190 million women and girls of reproductive age worldwide have endometriosis. - The American Cancer Society projected in January 2023 that 13,960 new invasive cervical cancer cases and 4,310 related deaths would occur in the U.S. in 2023.

What's next: - The market is expected to keep expanding through 2030 as providers adopt more digital, outpatient and minimally invasive gynecological care. - Report buyers will likely focus on regional growth hotspots, product categories tied to diagnosis and early detection, and devices designed for patient comfort and workflow efficiency. - The Business Research Company says the 2026 edition includes updated forecasting tools and graphics for buyers tracking future demand.

The bottom line: - Gynecological devices are moving from steady demand to faster growth, powered by rising disease burden, broader access to care and new technology adoption.